Answer
No, the safety and efficacy of tenofovir disoproxil succinate have not been established in children under two years with HIV-1 or chronic hepatitis B, and no data are available.
Sources for this answer
- Tenofovir disoproxil Dr. Reddys 245 mg Film-Coated TabletsDr. Reddy's Laboratories (UK) Ltd · emc · SmPC §4.2 Posology and method of administration · Version 12Document updated
Sources checked